- Lobbying
- Lobbying by IBEX Biosciences
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Joseph Eannello | Legislative Dir., Rep. Kevin Yoder; Sr. Legislative Assist., Rep. Yoder; Legislative Asst., Rep. Yoder; Legislative Corresp., Rep. Yoder; Legislative Asst., Rep. Jerry Weller; Legislative Corresp., Rep. Jerry Weller; Staff Asst., Rep. Jerry Weller. |
Jonathan Kott | Sr. Advisor & Communications Dir., Sen. Joe Manchin; Sr. Advisor & Communications Dir., Sen. Chris Coons; Press Sec., Rep. Brad Ellsworth; Press Sec., Rep. Anthony Weiner; Speechwriter, Sen. Evan Bayh; Public Affrs. Spec., Ofc. of the Director, OPM. |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Registration
Issue(s) they said they’d lobby about: Advocacy in support of federal funding for a GMP Facility related to biopharmaceutical development..
Registration
Issue(s) they said they’d lobby about: Advocacy related to the development of therapies for various medical issues, particularly for the treatment of Malaria. Advocacy in support of federal funding for a GMP Facility related to biopharmaceutical development..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate